| 000 | 01689cam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 110117s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2010.Em.E | ||
| 100 | 0 | _aEman Alhussain Abdulgawad | |
| 245 | 1 | 0 |
_aEvaluation of a new tumour marker in patients with non - small cell lung cancer CYFRA 21 - 1 / _cEman Alhussain Abdulgawad ; Supervised Sarah Mahmoud Fahmy Elkateb , Mohamed Shehata Abdallah , Hossam Hosni Masoud |
| 246 | 1 | 5 | _aتقييم دلالة اورام جديدة فى مرضى سرطان الرئة غير صغير الخلية سيفرا 21 - 1 |
| 260 |
_aCairo : _bEman Alhussain Abdulgawad , _c2010 |
||
| 300 |
_a123P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aLung cancer is one of the most common fatal malignancies . Cyfra 21 - 1 is a tumor marker based on the determination of water - soluble cytokeratin 19 which is secreted by normal or malignantly transformed epithelial cells . It is suggested to be a valuable marker in the diagnosis of patients with lung cancer especially non - small cell type (NSCLC) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCyfra 21 - 1 | |
| 653 | 4 | _aLung cancer | |
| 653 | 4 | _aNon small cell lung cancer | |
| 700 | 0 |
_aHossam Hosni Masoud , _eSupervisor |
|
| 700 | 0 |
_aMohamed Shehata Abdallah , _eSupervisor |
|
| 700 | 0 |
_aSarah Mahmoud Fahmy Elkateb , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c32715 _d32715 |
||